Literature DB >> 28175989

Predictors of Health-Related Quality of Life in boys with Duchenne muscular dystrophy from six European countries.

Christiane Otto1, Birgit F Steffensen2, Ann-Lisbeth Højberg3, Claus Barkmann1, Jes Rahbek3, Ulrike Ravens-Sieberer1, Annette Mahoney3, Julia Vry4, Kathrin Gramsch4, Rachel Thompson5, Sunil Rodger5, Kate Bushby5, Hanns Lochmüller5, Janbernd Kirschner4.   

Abstract

Duchenne muscular dystrophy (DMD) is a progressive, genetically determined neuromuscular disease that affects males and leads to severe physical disability in early teenage years. Over the last decades, patient-reported outcomes such as Health-Related Quality of Life (HRQoL) gained great interest in clinical research. However, little is known about factors affecting HRQoL in boys with DMD. Data from the multi-center CARE-NMD project of boys with DMD from six European countries collected between 2011 and 2012 were analyzed (8-17 years old; n = 321). HRQoL was measured using the KIDSCREEN-10 index, the Pediatric Quality of Life Inventory (PedsQL) and the Neuromuscular Module of the PedsQL (NMM). Linear regression models served to examine influences of socio-demographic, disease- and treatment-specific as well as participation- and environment-related factors on overall and disease-specific HRQoL. Proportions of explained variance varied across models using different outcomes (18-34%). Overall HRQoL according to the KIDSCREEN-10 index was associated with household income, the frequency of attending a clinic with specialized staff, the number of days spent outside home, and the attitude of the local community, but no significant association with age occurred. Overall HRQoL according to the generic PedsQL and disease-specific HRQoL were both positively associated with age and influenced by the country of residence, the disease stage, number of days spent outside home, and the attitude of the local community. Our results may be relevant for clinical practice and planning interventions for this population, but should be confirmed by future research. Further questions for future studies on boys with DMD are proposed.

Entities:  

Keywords:  Children and adolescents; Duchenne muscular dystrophy; Europe; Health-Related Quality of Life; Linear regression; Psychosocial health

Mesh:

Year:  2017        PMID: 28175989     DOI: 10.1007/s00415-017-8406-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

1.  Factors Associated With Health-Related Quality of Life in Children With Duchenne Muscular Dystrophy.

Authors:  Yi Wei; Kathy Nixon Speechley; Guangyong Zou; Craig Campbell
Journal:  J Child Neurol       Date:  2016-02-10       Impact factor: 1.987

2.  Socioeconomic determinants of health related quality of life in childhood and adolescence: results from a European study.

Authors:  Ursula von Rueden; Angela Gosch; Luis Rajmil; Corinna Bisegger; Ulrike Ravens-Sieberer
Journal:  J Epidemiol Community Health       Date:  2006-02       Impact factor: 3.710

3.  The PedsQL in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales.

Authors:  Sarah E Davis; Linda S Hynan; Christine A Limbers; C Mariam Andersen; Medrith C Greene; James W Varni; Susan T Iannaccone
Journal:  J Clin Neuromuscul Dis       Date:  2010-03

4.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

5.  Age and gender differences in health-related quality of life of children and adolescents in Europe: a multilevel analysis.

Authors:  Gisela Michel; Corinna Bisegger; Daniela C Fuhr; Thomas Abel
Journal:  Qual Life Res       Date:  2009-09-22       Impact factor: 4.147

Review 6.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

7.  The PedsQL 4.0 as a school population health measure: feasibility, reliability, and validity.

Authors:  James W Varni; Tasha M Burwinkle; Michael Seid
Journal:  Qual Life Res       Date:  2006-03       Impact factor: 4.147

8.  Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health.

Authors:  Roxanna M Bendixen; Claudia Senesac; Donovan J Lott; Krista Vandenborne
Journal:  Health Qual Life Outcomes       Date:  2012-05-22       Impact factor: 3.186

9.  European Cross-Sectional Survey of Current Care Practices for Duchenne Muscular Dystrophy Reveals Regional and Age-Dependent Differences.

Authors:  Julia Vry; Kathrin Gramsch; Sunil Rodger; Rachel Thompson; Birgit F Steffensen; Jes Rahbek; Sam Doerken; Adrian Tassoni; María de Los Angeles Beytía; Velina Guergueltcheva; Teodora Chamova; Ivailo Tournev; Anna Kostera-Pruszczyk; Anna Kaminska; Anna Lusakowska; Lenka Mrazova; Lenka Pavlovska; Jana Strenkova; Petr Vondráček; Marta Garami; Veronika Karcagi; Ágnes Herczegfalvi; Katherine Bushby; Hanns Lochmüller; Janbernd Kirschner
Journal:  J Neuromuscul Dis       Date:  2016-11-29

10.  The European KIDSCREEN approach to measure quality of life and well-being in children: development, current application, and future advances.

Authors:  Ulrike Ravens-Sieberer; Michael Herdman; Janine Devine; Christiane Otto; Monika Bullinger; Matthias Rose; Fionna Klasen
Journal:  Qual Life Res       Date:  2013-05-18       Impact factor: 4.147

View more
  9 in total

1.  Health-related quality of life in Spanish coeliac children using the generic KIDSCREEN-52 questionnaire.

Authors:  Josefa Barrio; María Luz Cilleruelo; Enriqueta Román; Cristina Fernández
Journal:  Eur J Pediatr       Date:  2018-07-16       Impact factor: 3.183

Review 2.  Developing multidisciplinary clinics for neuromuscular care and research.

Authors:  Sabrina Paganoni; Katie Nicholson; Fawn Leigh; Kathryn Swoboda; David Chad; Kristin Drake; Kellen Haley; Merit Cudkowicz; James D Berry
Journal:  Muscle Nerve       Date:  2017-08-29       Impact factor: 3.217

3.  Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: A qualitative preference study of patients and parents.

Authors:  Holly Landrum Peay; Ryan Fischer; Janice P Tzeng; Sharon E Hesterlee; Carl Morris; Amy Strong Martin; Colin Rensch; Edward Smith; Valeria Ricotti; Katherine Beaverson; Hannah Wand; Carol Mansfield
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

Review 4.  Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophy.

Authors:  Erik Landfeldt; Hanns Lochmüller; Peter Lindgren
Journal:  Orphanet J Rare Dis       Date:  2019-04-02       Impact factor: 4.123

5.  Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best-worst scaling experiment in caregivers and adult patients.

Authors:  Ryan S Paquin; Ryan Fischer; Carol Mansfield; Brennan Mange; Katherine Beaverson; Annie Ganot; Amy Strong Martin; Carl Morris; Colin Rensch; Valeria Ricotti; Leo J Russo; Alesia Sadosky; Edward C Smith; Holly L Peay
Journal:  Orphanet J Rare Dis       Date:  2019-05-09       Impact factor: 4.123

6.  Adapting traditional content validation methods to fit purpose: an example with a novel video assessment and training materials in Duchenne muscular dystrophy (DMD).

Authors:  Michelle K White; Mindy Leffler; Kaitlin Rychlec; Chris Jones; Christine McSherry; Linsey Walker; Mark Kosinski
Journal:  Qual Life Res       Date:  2019-07-13       Impact factor: 4.147

7.  Perspectives on Everyday Life Challenges of Danish Young People With Duchenne Muscular Dystrophy (DMD) on Corticosteroids.

Authors:  Charlotte Handberg; Ulla Werlauff; Ann-Lisbeth Højberg
Journal:  Glob Qual Nurs Res       Date:  2022-04-27

Review 8.  Duchenne and Becker muscular dystrophy in adolescents: current perspectives.

Authors:  Jennifer G Andrews; Richard A Wahl
Journal:  Adolesc Health Med Ther       Date:  2018-03-15

9.  Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies.

Authors:  Stephanie R Keller; Eric J Mallack; Jennifer P Rubin; Jennifer A Accardo; Jennifer A Brault; Camille S Corre; Camila Elizondo; Jennifer Garafola; April C Jackson-Garcia; Jullie Rhee; Elisa Seeger; Kaprice C Shullanberger; Amanda Tourjee; Melissa K Trovato; Amy T Waldman; Jenna L Wallace; Michael R Wallace; Klaus Werner; Angela White; Kevin C Ess; Catherine Becker; Florian S Eichler
Journal:  J Child Neurol       Date:  2020-09-02       Impact factor: 1.987

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.